All members have the option of attending our various HTC-centric events which include:
Date: Thursday, October 12, 2023 Time: 1:00pm - 2:00pm ET TITLE: A Label Update on Rebinyn, (Coagulation Factor IX (Recombinant), GlycoPEGylated: FDA Approval for a Prophylaxis Indication for Persons with Read the full article...
Date: October 18th - 20th (Atlanta, GA) Click here for info.
Date: Tuesday, October 24, 2023 Time: 2:00pm - 3:00pm ET TITLE: A Clinical Overview and Update from Sanofi for Efanesoctocog Alfa, A High Sustained Factor VIII Therapy OBJECTIVES: Highlighting both Read the full article...
Date: Tuesday, November 7, 2023 Time: 2:00pm - 3:00pm ET TITLE: Case Studies of Using BeneFix® (Coagulation Factor IX ) in Different Hemophilia B Patient Populations in an Evolving Treatment Read the full article...
Date: Thursday, November 9, 2023 Time: 1:00pm - 2:00pm ET TITLE: Learn More About Subcutaneous Prophylaxis Treatment for Hemophilia A: A Discussion on the Latest Data and Patient Management DESCRIPTION: Read the full article...
Location: Redondo Beach, California Venue: The Portofino Hotel & Marina Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727.688.2568. DRAFT AGENDA Friday: 8 am to Read the full article...
Date: Monday, November 13, 2023 Time: 1:00pm - 2:00pm ET TITLE: Hemgenix Real World Learnings SPEAKER: Vidhi Desai, MD Senior Medical Director, Coagulation North America Medical Affairs Vidhi Desai joined Read the full article...
Date: Friday, November 17, 2023 Time: 1:00pm - 2:00pm ET TOPIC: Clinical review of the Jivi® PROTECT VIII Trial and insights from HEM-POWR: A Real-World Evidence (RWE) Study of Jivi® Read the full article...
Date: Monday, November 27, 2023 Time: 1:00pm - 2:00pm ET TITLE: A different treatment option for Inhibitor patients OBJECTIVE: This presentation will provide an overview of inhibitors and explore the Read the full article...
Date: Wednesday, November 29, 2023 Time: 1:00pm - 2:00pm ET TITLE: Overview of Adzynma (rADAMTS13) Prescribing Information OBJECTIVE: Inform on the new approval and prescribing information of Adzynma indicated for Read the full article...
Date: December 9th - 12th (San Diego, CA & Virtual) Click here for info.
Date: January 7 - 9 Location: Dallas, TX
Date: Tuesday, January 23, 2024 Time: 1:00pm - 2:00pm ET TITLE: Real-world Characterization of Female Hemophilia A Carriers in the US OBJECTIVE: Summarize recently published real-world data on Female Hemophilia Read the full article...
Date: January 24 - 26 Location: Charleston, South Carolina Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: Febuary 28 - March 1 Location: New Orleans, LA Please contact Jeff Amond with any questions regarding this registration at amond@hemoalliance.org or 608-206-3132.
Date: Tuesday, March 5, 2024 Time: 1:00pm - 2:00pm ET TITLE: Advocating for Access to Behavioral Health Treatment for the Bleeding Disorders Community WEBINAR OBJECTIVE: This presentation will educate HTC Read the full article...
Date: Thursday, March 14, 2024 Time: 1:00pm - 2:00pm ET TITLE: Exploring the Science and Possibilities of Gene Therapy in Hemophilia WEBINAR OVERVIEW: By attending this webinar, you will discover Read the full article...
Date: March 25 - 27 Location: TBD PLEASE NOTE REGISTRATION FOR THIS MEETING WILL CLOSE ON FEBRUARY 9, 2024. Please contact Theresa Parker with any questions regarding this registration at Read the full article...
Date: April 3rd (Pre-Summit Workshops) Date: April 4th - 6th (Chicago, IL & Virtual) Click here for info.
Date: April 15 - 18 Location: Washington, DC Monday 4/15 – Welcome Reception Tuesday 4/16 – Spring Members Meeting Wednesday 4/17 – Spring Members Meeting, Hill Day Training and Joe’s Read the full article...
